Company licenses novel deep learning-based epigenetic models from CUHK enabling the detection of 5hmC, 5mC hemimethylation, and 6mA in standard sequencing runsMENLO PARK, Calif., April 28, 2025 (GLOBE ...

MENLO PARK, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- PacBio (Nasdaq: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced it plans to improve on its ...

PacBio has announced plans to enhance its methylation detection capabilities in HiFi sequencing by licensing advanced methods from Professor Dennis Lo and his team at The Chinese University of ...

MENLO PARK, Calif. - Pacific Biosciences (NASDAQ:PACB), a $324.66 million market cap company trading near its 52-week low, has announced a licensing agreement with The Chinese University of Hong ...

(RTTNews) - Pacific Biosciences of California, Inc. (PACB), Monday announced that it has licensed novel deep learning-based DNA methylation detection technology from The Chinese University of Hong ...

MENLO PARK, Calif. - Pacific Biosciences (NASDAQ:PACB), a $324.66 million market cap company trading near its 52-week low, has announced a licensing agreement with The Chinese University of Hong Kong ...

Twist Bioscience has shown revenue growth from $54.4m in 2019 to potentially >$300m in 2024, but continues to post losses.